Contract HHSN266200400002C
Dynport Vaccine Company Llc · Department Of Health And Human Services · October 30, 2003
Dynport Vaccine Company Llc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on October 30, 2003 for $6.76 million of work in research and development in the physical, engineering, and life sciences. Performance is in Frederick, MD. The contract has been modified 14 times since the base award It uses cost-plus contract pricing. The most recent modification was on December 11, 2013.
Contract details
- PIID
- HHSN266200400002C
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Competition
- Not Competed
- NAICS
- 541710 · Research And Development In The Physical, Engineering, And Life Sciences
- Product / service
- R&D- Medical: Biomedical (Basic Research)
- Place of performance
- Frederick, MD
- First action
- October 30, 2003
- Latest action
- December 11, 2013
Description
TAS::75 0885::TAS NIAID DEVELOPMENT TESTING AND EVALUATION OF A LIVE ATTENUATED (LVS) TULAREMIA VACCINE CANDIDATE
Modification timeline
-
December 11, 2013Mod 17$0
-
August 15, 2012Mod 16$-30.2K
-
May 1, 2012Mod 15$-1.25M
-
September 16, 2010Mod 14$0
-
December 28, 2009Mod 13DEVELOPMENT, TESTING, AND EVALUATION OF A LIVE ATTENUATED TULAREMIA (LVS) VACCINE CANDIDATE$0
-
September 30, 2009Mod 12DEVELOPMENT, TESTING, AND EVALUATION OF A LIVE ATTENUATED TULAREMIA (LVS) VACCINE CANDIDATE$-34.1K
-
August 11, 2009Mod 11DEVELOPMENT, TESTING, AND EVALUATION OF A LIVE ATTENUATED TULAREMIA (LVS) VACCINE CANDIDATE$0
-
May 19, 2009Mod 10DEVELOPMENT, TESTING, AND EVALUATION OF A LIVE ATTENUATED TULAREMIA (LVS) VACCINE CANDIDATE$0
-
December 29, 2008Mod 9DEVELOPMENT, TESTING, AND EVALUATION OF A LIVE ATTENUATED (LVS) VACCINE CANDIDATE$0
-
March 25, 2008Mod 8DEVELOPMENT, TESTING, AND EVALUATION OF A LIVE ATTENUATED (LVS) VACCINE CANDIDATE$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Tns Custom Research, Inc. | Department Of Health And Human Services | January 28, 2026 | $77.4K |
| Tns Custom Research, Inc. | Department Of Health And Human Services | January 28, 2026 | $17.6K |
| Ustav Fotoniky A Elektroniky Av Cr, V.V.I. | Department Of Health And Human Services | October 28, 2025 | $0 |
| Eastern Research Group Inc | Department Of Health And Human Services | September 22, 2025 | $0 |
| Eastern Research Group Inc | Department Of Health And Human Services | September 27, 2024 | $61.0K |
| Eastern Research Group Inc | Department Of Health And Human Services | September 17, 2024 | $130 |
Top contractors in NAICS 541710
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Regents Of The University Of California, The | 4 | $42.88B |
| 2 | Lawrence Livermore National Security, Llc | 1 | $40.78B |
| 3 | Battelle Memorial Institute | 3 | $30.29B |
| 4 | The Regents Of The University Of California | 6 | $21.41B |
| 5 | Lockheed Martin Corp | 75 | $18.50B |
| 6 | Uchicago Argonne, Llc | 2 | $17.14B |
| 7 | Lockheed Martin Corp | 34 | $16.50B |
| 8 | The Leland Stanford Junior University | 29 | $15.78B |
| 9 | California Institute Of Technology | 1,543 | $14.83B |
| 10 | United Space Alliance, Llc | 2 | $12.39B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN266200400002C?
Contract HHSN266200400002C is a federal contract awarded to Dynport Vaccine Company Llc by Department Of Health And Human Services on October 30, 2003 for $6.76 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES. It has been modified 14 times since the base award.
Who won contract HHSN266200400002C?
Dynport Vaccine Company Llc won contract HHSN266200400002C from Department Of Health And Human Services.
How much is contract HHSN266200400002C worth?
Contract HHSN266200400002C has obligated $6.76 million to date, with a total potential value of $8.09 million if all options are exercised.